lobbying_activities: 1521755

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1521755	e2227ff2-2ca4-49f5-b9c3-383cf380a92f	Q1	CROSSROADS STRATEGIES, LLC	400531586	LUMARA HEALTH	2014	first_quarter	PHA	Implementation issues related to the Pharmaceutical Quality, Security, and Accountability Act (P.L. 113-54); H.R.3089, Compounding Clarity Act of 2013; FDA related issues-specifically pharmacy compounding.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2014-04-17T11:32:45.800000-04:00